AMANTA • ISIN: INE084K01015
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company markets products through three business units:
National sales,
International sales and
Product partnering with various foreign and Indian pharmaceutical companies.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.
Competitive Strengths
Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
Large manufacturing capabilities
Wide Domestic and International Marketing Network.
Experienced management team supported by a large, diverse and skilled workforce.
Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
General corporate purposes
Price Band
Min Investment
Lot Size
P/E Ratio
Issue Opens
1 Sept 2025
Issue Closes
3 Sept 2025
Allotment
4 Sept 2025
Listing
9 Sept 2025
Qualified Institutional Investors
57,851,136 / 2,000,000 shares
High Networth Individuals (Above ₹10 Lakhs)
158,988,879 / 1,000,000 shares
Non-Institutional Investors (Below ₹10 Lakhs)
56,580,216 / 500,000 shares
Retail Individual Investors
122,010,581 / 3,500,000 shares
Issue Type | BB |
Face Value | ₹10 |
Lead Managers | Beeline Capital Advisors Pvt.Ltd. |
Min Quantity | 119 |
Max Quantity | 3,968 |
Company Promoters | Bhavesh Patel Vishal Patel Jayshreeben Patel +2 more |
Website | |
Phone | 079 67777600 |
Address | Amanta Healthcare Ltd. |